CVS Group plc, a leading provider of integrated veterinary services in the UK and Australia, has confirmed that no employees exercised options during May under the CVS Group SAYE Plans. As a result, the company's total issued share capital remains at 71,721,269 Ordinary Shares, each carrying one voting right, with no Ordinary Shares held in treasury. This figure will be used by shareholders as the denominator for the calculations to determine if they are required to notify their interest or a change to their interest in the company under the FCA's Disclosure Guidance and Transparency Rules.
The company's leadership team includes Richard Fairman, CEO, and Scott Morrison, Company Secretary. CVS Group plc is listed on AIM and is supported by Peel Hunt LLP as the Nominated Adviser & Broker and Berenberg as the Joint Broker. Camarco provides financial PR for the company.
CVS Group plc operates approximately 460 veterinary practices across the UK and Australia, including specialist referral hospitals and dedicated out-of-hours sites. In addition to the core Veterinary Practices division, CVS operates Laboratories, providing diagnostic services to CVS and third-parties, Crematoria for pet cremation and clinical waste disposal, and an online retail business called "Animed Direct."
For more information about CVS Group plc, visit www.cvsukltd.co.uk.